VivoSeq
Other

Prematurity

1

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Prematurity is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

17/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Measurement of Intestinal Permeability

University of Maryland, Baltimore

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

6

clinical trials

Recruiting2 · 33%
Completed2 · 33%
Terminated1 · 17%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.
Recruiting·KKK Women's and Children's Hospital·N/A·NCT06048614·95 enrolled
Clinical Management and Short-Term Outcomes of Neonates Born at 22 Weeks in the UK (The 22 Week Study)
Recruiting·IImperial College London·N/A·NCT07616778·100 enrolled
Gut Permeability and Microbiome in Very Low Birth Weight Preterm Neonates.
Not yet recruiting·UUniversity of Maryland, Baltimore·Phase 1·NCT07667049·150 enrolled
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
Completed·—·Phase 4·NCT01683565·31 enrolled
Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin)
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT00718705·3,200 enrolled
Registration and Treatment of Pain During Eye Examination of Prematurity
Terminated·SSt. Olavs Hospital·N/A·NCT01552993·5 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)